Background and Need for Legislation
Every year, about 42,000 women die from breast cancer in
the United States.\1\ Among women in the U.S., breast cancer is
the second most common cancer and the second leading cause of
cancer death.\2\ Early detection of breast cancer can improve
patient outcomes by catching cancer when it is easiest to
treat.\3\ According to the Centers for Disease Control and
Prevention (CDC), roughly 270,000 women are diagnosed with
breast cancer on an annual basis.\4\ In 2022, a total of 27,136
new cases of breast cancer were reported in women younger than
45 years in the United States.\5\ About 10 percent of all
breast cancer cases in the United States are found in women
younger than 45.\6\
---------------------------------------------------------------------------
\1\Ctrs. for Disease Control and Prevention (CDC), Breast Cancer
Awareness (Jul. 30, 2025), https://www.cdc.gov/cancer/features/breast-
cancer.html.
\2\CDC, Breast Cancer Statistics (Jun. 10, 2025); https://
www.cdc.gov/breast-cancer/statistics/index.html.
\3\CDC, Health and Economic Benefits of Breast Cancer Interventions
(Aug. 14, 2025), https://www.cdc.gov/nccdphp/priorities/breast-
cancer.html.
\4\CDC, supra note 1.
\5\CDC, United States Cancer Statistics, Breast Cancer Among Women
Younger Than 45 (Aug. 15, 2025), https://www.cdc.gov/united-states-
cancer-statistics/publications/breast-cancer-among-young-women.html.
\6\CDC, Bring Your Brave Campaign, About the Bring Your Brave
Campaign (Sept. 24, 2024), https://www.cdc.gov/bring-your-brave/about/
index.html.
---------------------------------------------------------------------------
First enacted in 2009, the EARLY Act has been credited with
driving national progress in breast cancer awareness and
prevention. The legislation directs the CDC to lead initiatives
to increase knowledge of breast health and breast cancer among
women, particularly those younger than 45 and those at higher
risk for developing the disease.\7\ CDC's efforts to encourage
breast health and prevent young women's breast cancer include,
but are not limited to, promoting an educational campaign for
health care professionals across HHS; conducting research on
breast cancer prevention in younger women; and awarding grants
to provide support and health information to young women
diagnosed with cancer and other pre-neoplastic diseases.
---------------------------------------------------------------------------
\7\CDC, Breast Cancer, Advisory Committee on Breast Cancer in Young
Women (Sept. 3, 2025), https://www.cdc.gov/breast-cancer/php/advisory-
committee/index.html.
---------------------------------------------------------------------------
When diagnosed at the earliest stage, almost 98 percent of
women diagnosed with breast cancer live for 5 years or more,
compared to about 31 percent of those diagnosed at the most
advanced stage.\8\ The CDC's National Breast and Cervical
Cancer Early Detection Program (NBCCEDP) provides access to
breast cancer screening and diagnostic services for low-income
American women, including American Indian and Alaska Native
women. The NBCCEDP also provides public education, outreach,
patient navigation, and care coordination services to increase
breast and cervical cancer screening rates and reach
underserved populations. Over the past 35 years, NBCCEDP has
served more than 6.6 million women, diagnosed 82,827 invasive
breast cancers and 26,357 premalignant breast lesions, and
diagnosed 5,422 invasive cervical cancers and 259,537
premalignant cervical lesions, of which 38 percent were high-
grade.\9\
---------------------------------------------------------------------------
\8\Id.
\9\CDC, About the National Breast and Cervical Cancer Early
Detection Program (Feb. 20, 2026), https://www.cdc.gov/breast-cervical-
cancer-screening/about/index.html.
---------------------------------------------------------------------------
Committee Action
On April 15, 2026, the Subcommittee on Health held a
legislative hearing on H.R. 4541. The title of the hearing was
``Healthier America: Legislative Proposals to Improve Public
Health.'' The Subcommittee received testimony from:
Jamie Ulmer, MA, President and CEO,
Healthcare Network
Rachel F. Brem, MD, FACR, FSBI, Co-Founder,
Chief Medical Officer, Brem Foundation to Defeat Breast
Cancer and Professor and Vice-Chair Emeritus, The
George Washington University
Holly Ahern, MS, MT(ASCP), Associate
Professor of Microbiology, State University of New York
Adirondack
Amy L. Ronneberg, MBA, Chief Executive
Officer, National Marrow Donor Program
Brian Wallach & Sandra Abrevaya, Co-
Founders, I AM ALS
Rene Quashie, JD, Vice President, Digital
Health, Consumer Technology Association
On May 13, 2026, the Subcommittee on Health met in open
markup session and forwarded H.R. 4541, without amendment, to
the full Committee by a voice vote.
On May 21, 2026, the full Committee on Energy and Commerce
met in open markup session and ordered H.R. 4541, as amended,
favorably reported to the House by a record vote of 48 yeas and
0 nays.
Congressional Budget Office Estimate
Pursuant to clause 3(c)(3) of rule XIII, at the time this
report was filed, the cost estimate prepared by the Director of
the Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974 was not available.
Federal Mandates Statement
The Committee adopts as its own the estimate of Federal
mandates prepared by the Director of the Congressional Budget
Office pursuant to section 423 of the Unfunded Mandates Reform
Act.
Statement of General Performance Goals and Objectives
Pursuant to clause 3(c)(4) of rule XIII, the general
performance goal or objective of this legislation is to improve
the ability for communities to detect breast cancer and
cervical cancer at early stages.
Duplication of Federal Programs
Pursuant to clause 3(c)(5) of rule XIII, no provision of
H.R. 4541 is known to be duplicative of another Federal
program, including any program that was included in a report to
Congress pursuant to section 21 of Public Law 111-139 or the
most recent Catalog of Federal Domestic Assistance.
Related Committee and Subcommittee Hearings
Pursuant to clause 3(c)(6) of rule XIII, the following
related hearing was used to develop or consider H.R. 4541:
On April 15, 2026, the Subcommittee on
Health held a legislative hearing on H.R. 4541. The
title of the hearing was ``Healthier America:
Legislative Proposals to Improve Public Health.'' The
Subcommittee received testimony from:
Jamie Ulmer, MA, President and
CEO, Healthcare Network;
Rachel F. Brem, MD, FACR, FSBI,
Co-Founder, Chief Medical Officer, Brem
Foundation to Defeat Breast Cancer and
Professor and Vice-Chair Emeritus, The George
Washington University;
Holly Ahern, MS, MT(ASCP),
Associate Professor of Microbiology, State
University of New York Adirondack;
Amy L. Ronneberg, MBA, Chief
Executive Officer, National Marrow Donor
Program;
Brian Wallach & Sandra Abrevaya,
Co-Founders, I AM ALS; and,
Rene Quashie, JD, Vice
President, Digital Health, Consumer Technology
Association.
Committee Cost Estimate
Pursuant to clause 3(d)(1) of rule XIII, the Committee
adopts as its own the cost estimate prepared by the Director of
the Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974. At the time this report was
filed, the estimate was not available.
Earmark, Limited Tax Benefits, and Limited Tariff Benefits
Pursuant to clause 9(e), 9(f), and 9(g) of rule XXI, the
Committee finds that H.R. 4541 contains no earmarks, limited
tax benefits, or limited tariff benefits.
Advisory Committee Statement
No advisory committees within the meaning of section 5(b)
of the Federal Advisory Committee Act were created by this
legislation.
Applicability to Legislative Branch
The Committee finds that the legislation does not relate to
the terms and conditions of employment or access to public
services or accommodations within the meaning of section
102(b)(3) of the Congressional Accountability Act.
Section-by-Section Analysis of the Legislation
Section 101. Short title
Section 101 provides a short title of ``EARLY Act
Reauthorization of 2025.''
Section 102. Reauthorization of the Young Women's Breast Health
Education and Awareness Requires Learning Young Act of 2009
Section 102 reauthorizes the Young Women's Breast Health
Education and Awareness Requires Learning Young Act of 2009
through 2031.
Section 201. Short title
Section 201 provides a short title of Screening for
Communities to Receive Early and Equitable Needed Services for
Cancer Act of 2025'' or the ``SCREENS for Cancer Act of 2025.''
Section 202. National Breast and Cervical Cancer Early Detection
Program
Section 202 reauthorizes the National Breast and Cervical
Cancer Early Detection Program through 2030. This section also
makes updates to the program to reduce disparities and support
certain activities that improve cancer screening rates.
Finally, this section requires that the Government
Accountability Office (GAO) conduct a report on the program,
including an estimate of the number of eligible individuals,
the trends among the individuals served, and an assessment of
underlying factors for such trends.
Changes in Existing Law Made by the Bill, as Reported
In compliance with clause 3(e) of rule XIII of the Rules of
the House of Representatives, changes in existing law made by
the bill, as reported, are shown as follows (existing law
proposed to be omitted is enclosed in black brackets, new
matter is printed in italics, and existing law in which no
change is proposed is shown in roman):
PUBLIC HEALTH SERVICE ACT
* * * * * * *
TITLE III--GENERAL POWERS AND DUTIES OF PUBLIC HEALTH SERVICE
* * * * * * *
PART V--PROGRAMS RELATING TO BREAST HEALTH AND CANCER
* * * * * * *
SEC. 399NN. YOUNG WOMEN'S BREAST HEALTH AWARENESS AND SUPPORT OF YOUNG
WOMEN DIAGNOSED WITH BREAST CANCER.
(a) Public Education Campaign.--
(1) In general.--The Secretary, acting through the
Director of the Centers for Disease Control and
Prevention, shall conduct a national evidence-based
education campaign to increase awareness of young
women's knowledge regarding--
(A) breast health in young women of all
racial, ethnic, and cultural backgrounds;
(B) breast awareness and good breast health
habits;
(C) the occurrence of breast cancer and the
general and specific risk factors in women who
may be at high risk for breast cancer based on
familial, racial, ethnic, and cultural
backgrounds such as Ashkenazi Jewish
populations;
(D) evidence-based information that would
encourage young women and their health care
professional to increase early detection of
breast cancers; and
(E) the availability of health information
and other resources for young women diagnosed
with breast cancer.
(2) Evidence-based, age appropriate messages.--The
campaign shall provide evidence-based, age-appropriate
messages and materials as developed by the Centers for
Disease Control and Prevention and the Advisory
Committee established under paragraph (4).
(3) Media campaign.--In conducting the education
campaign under paragraph (1), the Secretary shall award
grants to entities to establish national multimedia
campaigns oriented to young women that may include
advertising through television, radio, print media,
billboards, posters, all forms of existing and
especially emerging social networking media, other
Internet media, and any other medium determined
appropriate by the Secretary.
(4) Advisory committee.--
(A) Establishment.--Not later than 60 days
after the date of the enactment of this
section, the Secretary, acting through the
Director of the Centers for Disease Control and
Prevention, shall establish an advisory
committee to assist in creating and conducting
the education campaigns under paragraph (1) and
subsection (b)(1).
(B) Membership.--The Secretary, acting
through the Director of the Centers for Disease
Control and Prevention, shall appoint to the
advisory committee under subparagraph (A) such
members as deemed necessary to properly advise
the Secretary, and shall include organizations
and individuals with expertise in breast
cancer, disease prevention, early detection,
diagnosis, public health, social marketing,
genetic screening and counseling, treatment,
rehabilitation, palliative care, and
survivorship in young women.
(b) Health Care Professional Education Campaign.--The
Secretary, acting through the Director of the Centers for
Disease Control and Prevention, and in consultation with the
Administrator of the Health Resources and Services
Administration, shall conduct an education campaign among
physicians and other health care professionals to increase
awareness--
(1) of breast health, symptoms, and early diagnosis
and treatment of breast cancer in young women,
including specific risk factors such as family history
of cancer and women that may be at high risk for breast
cancer, such as Ashkenazi Jewish population;
(2) on how to provide counseling to young women about
their breast health, including knowledge of their
family cancer history and importance of providing
regular clinical breast examinations;
(3) concerning the importance of discussing healthy
behaviors, and increasing awareness of services and
programs available to address overall health and
wellness, and making patient referrals to address
tobacco cessation, good nutrition, and physical
activity;
(4) on when to refer patients to a health care
provider with genetics expertise;
(5) on how to provide counseling that addresses long-
term survivorship and health concerns of young women
diagnosed with breast cancer; and
(6) on when to provide referrals to organizations and
institutions that provide credible health information
and substantive assistance and support to young women
diagnosed with breast cancer.
(c) Prevention Research Activities.--The Secretary, acting
through--
(1) the Director of the Centers for Disease Control
and Prevention, shall conduct prevention research on
breast cancer in younger women, including--
(A) behavioral, survivorship studies, and
other research on the impact of breast cancer
diagnosis on young women;
(B) formative research to assist with the
development of educational messages and
information for the public, targeted
populations, and their families about breast
health, breast cancer, and healthy lifestyles;
(C) testing and evaluating existing and new
social marketing strategies targeted at young
women; and
(D) surveys of health care providers and the
public regarding knowledge, attitudes, and
practices related to breast health and breast
cancer prevention and control in high-risk
populations; and
(2) the Director of the National Institutes of
Health, shall conduct research to develop and validate
new screening tests and methods for prevention and
early detection of breast cancer in young women.
(d) Support for Young Women Diagnosed With Breast Cancer.--
(1) In general.--The Secretary shall award grants to
organizations and institutions to provide health
information from credible sources and substantive
assistance directed to young women diagnosed with
breast cancer and pre-neoplastic breast diseases.
(2) Priority.--In making grants under paragraph (1),
the Secretary shall give priority to applicants that
deal specifically with young women diagnosed with
breast cancer and pre-neoplastic breast disease.
(e) No Duplication of Effort.--In conducting an education
campaign or other program under subsections (a), (b), (c), or
(d), the Secretary shall avoid duplicating other existing
Federal breast cancer education efforts.
(f) Measurement; Reporting.--The Secretary, acting through
the Director of the Centers for Disease Control and Prevention,
shall--
(1) measure--
(A) young women's awareness regarding breast
health, including knowledge of family cancer
history, specific risk factors and early
warning signs, and young women's proactive
efforts at early detection;
(B) the number or percentage of young women
utilizing information regarding lifestyle
interventions that foster healthy behaviors;
(C) the number or percentage of young women
receiving regular clinical breast exams; and
(D) the number or percentage of young women
who perform breast self exams, and the
frequency of such exams, before the
implementation of this section;
(2) not less than every 3 years, measure the impact
of such activities; and
(3) submit reports to the Congress on the results of
such measurements.
(g) Definition.--In this section, the term ``young women''
means women 15 to 44 years of age.
(h) Authorization of Appropriations.--To carry out
subsections (a), (b), (c)(1), and (d), there are authorized to
be appropriated $9,000,000 for each of fiscal years 2022
through [2026] 2031.
* * * * * * *
TITLE XV--PREVENTIVE HEALTH MEASURES WITH RESPECT TO BREAST AND
CERVICAL CANCERS
SEC. 1501. ESTABLISHMENT OF PROGRAM OF GRANTS TO STATES.
(a) In General.--The Secretary, acting through the Director
of the Centers for Disease Control and Prevention, may make
grants to States on the basis of an established competitive
review process for the purpose of carrying out programs--
(1) to screen women for breast and cervical cancer as
a preventive health measure;
(2) to provide appropriate referrals for medical
treatment of women screened pursuant to paragraph (1)
and to ensure, to the extent practicable, [the
provision of appropriate follow-up services and support
services such as case management] that appropriate
follow-up services are provided;
(3) to develop and disseminate public information and
education [programs for the detection and control]
programs for the prevention, detection, and control of
breast and cervical cancer;
(4) to improve the education, training, and skills of
health professionals (including allied health
professionals) in [the detection and control] the
prevention, detection, and control of breast and
cervical cancer;
(5) to establish mechanisms through which the States
can [monitor] ensure the quality of screening
procedures for breast and cervical cancer, including
the interpretation of such procedures[; and];
(6) to enhance appropriate support activities to
increase breast and cervical cancer screenings, such as
navigation of health care services, implementation of
evidence-based or evidence-informed strategies to
increase breast and cervical cancer screening in health
care settings, and facilitation of access to health
care settings;
(7) to reduce disparities in breast and cervical
cancer incidence, morbidity, and mortality, including
in populations with higher than average rates;
(8) to improve access to breast and cervical cancer
screening and diagnostic services and reduce related
barriers, including factors that relate to negative
health outcomes; and
[(6)] (9) to evaluate activities conducted under
paragraphs (1) [through (5)] through (8) through
appropriate surveillance or program-monitoring
activities.
(b) Grant and Contract Authority of States.--
(1) In general.--A State receiving a grant under
subsection (a) may, subject to paragraphs (2) and (3),
expend the grant to carry out the purpose described in
such subsection through grants to public and nonprofit
private entities and through contracts with public and
private entities.
(2) Certain applications.--If a nonprofit private
entity and a private entity that is not a nonprofit
entity both submit applications to a State to receive
an award of a grant or contract pursuant to paragraph
(1), the State may give priority to the application
submitted by the nonprofit private entity in any case
in which the State determines that the quality of such
application is equivalent to the quality of the
application submitted by the other private entity.
(3) Payments for screenings.--The amount paid by a
State to an entity under this subsection for a
screening procedure under subsection (a)(1) may not
exceed the amount that would be paid under part B of
title XVIII of the Social Security Act if payment were
made under such part for furnishing the procedure to a
woman enrolled under such part.
(c) Special Consideration for Certain States.--In making
grants under subsection (a) to States whose initial grants
under such subsection are made for fiscal year 1995 or any
subsequent fiscal year, the Secretary shall give special
consideration to any State whose proposal for carrying out
programs under such subsection--
(1) has been approved through a process of peer
review; and
(2) is made with respect to geographic areas in which
there is--
(A) a substantial rate of mortality from
breast or cervical cancer; or
(B) a substantial incidence of either of such
cancers.
[(d) Coordinating Committee Regarding Year 2020 Health
Objectives.--The Secretary, acting through the Director of the
Centers for Disease Control and Prevention, shall establish a
committee to coordinate the activities of the agencies of the
Public Health Service (and other appropriate Federal agencies)
that are carried out toward achieving the objectives
established by the Secretary for reductions in the rate of
mortality from breast and cervical cancer in the United States
by the year 2020. Such committee shall be comprised of Federal
officers or employees designated by the heads of the agencies
involved to serve on the committee as representatives of the
agencies, and such representatives from other public or private
entities as the Secretary determines to be appropriate.]
* * * * * * *
SEC. 1503. REQUIREMENTS WITH RESPECT TO TYPE AND QUALITY OF SERVICES.
(a) Requirement of Prov